Trice Medical Closes $19.3 Million Series C Financing

Trice Medical announced today that it closed a $19.3 million Series C financing and will use the proceeds to accelerate and expand the company's U.S. market penetration for mi-eye2™, R&D, sales, marketing and key international regulatory approvals. Smith & Nephew (LSE:SN, NYSE: SNN), a global medical technology business dedicated to helping healthcare professionals improve people's lives, has taken a minority stake joining a consortium of current investors including Safeguard Scientifics (NYSE: SFE), HealthQuest Capital, BioStar Ventures and others in this latest funding round.